Thermo Fisher Scientific serves as an enabling solutions provider across the battery value chain, focusing on research, materials development, quality assurance, and manufacturing optimization. It offers advanced analytical instruments—mass spectrometry, molecular and elemental spectroscopy, electron microscopy—laboratory consumables and custom chemicals (metals, metal oxides, solvents, separators). The company supports lithium-ion, solid-state, sodium-ion and other emerging chemistries with high-resolution microscopy (SEM, TEM, PFIB-SEM), spectroscopy (XPS, Raman), specialized sample preparation, contamination-free analysis, process control, failure analysis and quality assurance.
Advanced analytical tools (mass spectrometers, molecular and elemental spectrometers, electron microscopes), laboratory consumables and custom chemicals (metals, metal oxides, solvents, separators), and specialized sample preparation workflows for battery materials.
In 2023, Thermo Fisher Scientific opened its Battery Customer Experience Center in Seoul, South Korea, providing battery manufacturers with metrology and quality control technologies, expert technical support and knowledge sharing to accelerate sustainable, high-performance battery development and manufacturing improvements.
As of mid-2025, major institutional investors in Thermo Fisher Scientific include Vanguard Fiduciary Trust Co. (8.9%), BlackRock Advisors LLC (5.5%), State Street Corporation (4.4%), Eaton Vance Management (3.1%), and Capital Research & Management Co. (2.9%). Approximately 60.0% of shares are held by U.S.-based institutional investors, with the remainder held internationally.
